Randomised high- and low-dose heparin prophylaxis in patients undergoing thoracotomy for benign and malignant disease: effect on thrombo-elastography

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 6, 2010, Pages 1384-1390

  Attaran, Saina ^a   Somov, Pavlo ^a   Awad, Wael I ^a  

^a LONDON CHEST HOSPITAL   (United Kingdom)

Author keywords

Hypercoagulability; Lung cancer; Thrombo embolism; Thromboprophylaxis

Indexed keywords

ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CHEMOPROPHYLAXIS; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; HYPERCOAGULABILITY; LOW DRUG DOSE; LUNG CANCER; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; SURGICAL PATIENT; THORACOTOMY; THORAX SURGERY; THROMBOELASTOGRAPHY; THROMBOSIS PREVENTION;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PREANESTHETIC MEDICATION; PREOPERATIVE CARE; PROSPECTIVE STUDIES; THORACOTOMY; THROMBELASTOGRAPHY; THROMBOEMBOLISM; THROMBOPHILIA; YOUNG ADULT;

EID: 77952585026     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.12.027     Document Type: Article

References (25)

1. Trousseau A. Phlegmasia alba dolens. Lectures on clinical medicine delivered at the Hotel-Dieu, Paris. 5th edn (1872), New Sydenham Society, London p. 281-95
2. Blom J.W., Doggen C.J., Osanto S., and Rosendaal F.R. Malignancies, prothrombotic mutations and the risk of venous thrombosis. J Am Med Assoc 293 (2005) 715-722
3. Baron J.A., Gridley G., Weiderpass E., Nyrén O., and Linet M. Venous thromboembolism and cancer. Lancet 351 (1998) 1077-1080
4. Geerts W.H., Bergqvist D., Pineo G.F., Heit J.A., Samama C.M., Lassen M.R., Colwell C.W., and American College of Chest Physicians. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 6 Suppl. (2008) 381S-453S
5. Geerts W.H., Pineo G.F., Heit J.A., Bergqvist D., Lassen M.R., Colwell C.W., and Ray J.G. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 September (3 Suppl.) (2004) 338S-400S
6. White R.H., Zhou H., and Romano P.S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 90 (2003) 446-455
7. Ziomek S., Read R.C., Tobler H.G., Harrell Jr. J.E., Gocio J.C., Fink L.M., Ranval T.J., Ferris E.J., Harshfield D.L., and McFarland D.R. Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg 56 (1993) 223-226
8. Klein S.M., Slaughter T.F., Vail P.T., Ginsberg B., El-Moalem H.E., Alexander R., D'ercole F., Greengrass R.A., Perumal T.M., Welsby I., and Gan T.J. Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: a comparison with anti-Xa concentrations. Anesth Analg 91 (2000) 1091-1095
9. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem neuen Untersuchungsverfahren. Klin Wochenscgr 26 (1948) 577-583
10. Spiess B.D., Gillies B.S.A., Chandler W., and Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 9 (1995) 168-173
11. McCrath D.J., Cerboni E., Frumento R.J., Hirsh A.L., and Bennett-Guerrero E. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesh Analg 100 (2005) 1576-1583
12. Rai R., Tuddenham E., Backos M., Jivraj S., El'Gaddal S., Choy S., Cork B., and Regan L. Thromboelastography, whole-blood haemostasis and recurrent miscarriage. Hum Reprod 18 (2003) 2540-2543
13. Park M.S., Martini W.Z., Dubick M.A., Salinas J., Butenas S., Kheirabadi B.S., Pusateri A.E., Vos J.A., Guymon C.H., Wolf S.E., Mann K.G., and Holcomb J.B. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma 67 (2009) 266-276
14. Gottlieb A., Mraovic B., Sprung J., Potter P., and Kottke-Marchant K. The usefulness of thromboelastography in determining the coagulation effects of low-molecular weight heparin. Anesth Analg 88 (1999) S1-S424
15. Zmuda K., Neofotistos D., and Ts'ao C.H. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation. Am J Clin Pathol 113 (2000) 725-731
16. Donahue S.M., and Otto C.M. Thromboelastography: a tool for measuring hypercoagulability, hypocoagulability, and fibrinolysis. J Vet Emerg Crit Care 15 (2005) 9-16
17. Sun N.C., McAfee W.M., Hum G.J., and Weiner J.M. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol 71 (1979) 10-16
18. Venous thromboembolism. Reducing the risk of venous thromboembolism in patients undergoing surgery. NICE clinical guidelines 46; April 2007.
19. Cestac P., Bagheri H., Lapeyre-Mestre M., Sié P., Fouladi A., Maupas E., Léger P., Fontan B., Massip P., and Montastruc J.L. Utilisation and safety of low molecular weight heparins: prospective observational study in medical inpatients. Drug Saf 26 3 (2003) 197-207
20. Vandermeulen E.P., Van Aken H., and Vermylen J. Anticoagulants and spinal-epidural anesthesia. Anesth Analg 79 (1994) 1165-1177
21. Simonneau G., Sors H., Charbonnier B., Page Y., Laaban J.P., Azarian R., Laurent M., Hirsch J.L., Ferrari E., Bosson J.L., Mottier D., and Beau B. A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med 337 10 (1997) 663-669
22. Levine M., Gent M., Hirsh J., Leclerc J., Anderson D., Weitz J., Ginsberg J., Turpie A.G., Demers C., Kovacs M., Geerts W., Kassis J., Desjardins L., Cusson J., Cruickshank M., Powers P., Brien W., Haley S., and Willan A. A comparison of low molecular weight heparin administered primarily at home with UFH administered in the hospital for proximal deep vein thrombosis. N Engl J Med 334 (1996) 677-681
23. Koopman M.M.W., Prandoni P., Piovella F., Ockelford P.A., Brandjes D.P.M., van der Meer J., Gallus A.S., Simonneau G., Chesterman C.H., Prins M.H., Bossuyt P.M.M., de Haes H., van den Belt A.G.M., Sagnard L., D'Azemar P., Buller H.R., and for the TASMAN Study Group. Treatment of venous thrombosis with intravenous UFH administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 334 (1996) 682-687
24. Leonard S.A., Lydon A., Walsh M., Fleming C., Boylan J., and Shorten G.D. Does prior administration of enoxaparin influence the effect of levobupivacaine on blood clotting? Assessment using the thromboelastograph. Br J Anaesth 86 (2001) 808-813
25. Klein S.M., Slaughter T.F., Vail P.T., Ginsberg B., El-Moalem H.E., Alexander R., D'ercole F., Greengrass R.A., Perumal T.M., Welsby I., and Gan T.J. Thromboelastography as a perioperative measure of anticoagulation resulting from low molecular weight heparin: A comparison with anti-Xa concentrations. Anesth Analg 91 (2000) 1091-1095